TCL Archive DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies May 19, 1989
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014